F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$75.24M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.39M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	40
Open	31.31
Previous Close	31.32
Day's Range	31.31 - 31.31
52-Week Low	18.78
52-Week High	32.92
Beta	n/a
Holdings	38
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

48.18% of assets

Name	Symbol	Weight
Travere Therapeutics, Inc.	TVTX	7.35%
Guardant Health, Inc.	GH	6.24%
LivaNova PLC	LIVN	5.66%
TransMedics Group, Inc.	TMDX	5.07%
Cogent Biosciences, Inc.	COGT	4.19%
BridgeBio Pharma, Inc.	BBIO	4.07%
Nektar Therapeutics	NKTR	4.00%
Soleno Therapeutics, Inc.	SLNO	3.93%
RadNet, Inc.	RDNT	3.89%
Madrigal Pharmaceuticals, Inc.	MDGL	3.78%

Performance

LFSC had a total return of 22.33% in the past year, including dividends. Since the fund's inception, the average annual return has been 24.73%.